Steven C Gilman - Net Worth and Insider Trading
Steven C Gilman Net Worth
The estimated net worth of Steven C Gilman is at least $1 Million dollars as of 2024-09-20. Steven C Gilman is the Director of Vericel Corp and owns about 11,000 shares of Vericel Corp (VCEL) stock worth over $528,330. Steven C Gilman is the Director of Momenta Pharmaceuticals Inc and owns about 7,796 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $409,134. Steven C Gilman is also the Director of Akebia Therapeutics Inc and owns about 43,430 shares of Akebia Therapeutics Inc (AKBA) stock worth over $59,499. Besides these, Steven C Gilman also holds Keryx Biopharmaceuticals Inc (KERX) , SCYNEXIS Inc (SCYX) , ContraFect Corp (CFRXQ) . Details can be seen in Steven C Gilman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven C Gilman has not made any transactions after 2024-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven C Gilman
Steven C Gilman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven C Gilman owns 6 companies in total, including Momenta Pharmaceuticals Inc (MNTA) , SCYNEXIS Inc (SCYX) , and Akebia Therapeutics Inc (AKBA) among others .
Click here to see the complete history of Steven C Gilman’s form 4 insider trades.
Insider Ownership Summary of Steven C Gilman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNTA | Momenta Pharmaceuticals Inc | 2020-10-01 | director |
| SCYX | SCYNEXIS Inc | 2023-06-15 | director |
| AKBA | Akebia Therapeutics Inc | 2022-06-03 | director |
 | | 2017-07-25 | director |
| | 2024-09-04 | director |
| | 2018-12-12 | director |
Steven C Gilman Latest Holdings Summary
Steven C Gilman currently owns a total of 6 stocks. Among these stocks, Steven C Gilman owns 11,000 shares of Vericel Corp (VCEL) as of September 4, 2024, with a value of $528,330 and a weighting of 49.76%. Steven C Gilman owns 7,796 shares of Momenta Pharmaceuticals Inc (MNTA) as of August 5, 2020, with a value of $409,134 and a weighting of 38.53%. Steven C Gilman also owns 43,430 shares of Akebia Therapeutics Inc (AKBA) as of June 3, 2022, with a value of $59,499 and a weighting of 5.6%. The other 3 stocks Keryx Biopharmaceuticals Inc (KERX) , SCYNEXIS Inc (SCYX) , ContraFect Corp (CFRXQ) have a combined weighting of 6.1% among all his current holdings.
Latest Holdings of Steven C Gilman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VCEL | Vericel Corp | 2024-09-04 | 11,000 | 48.03 | 528,330 |
| MNTA | Momenta Pharmaceuticals Inc | 2020-08-05 | 7,796 | 52.48 | 409,134 |
| AKBA | Akebia Therapeutics Inc | 2022-06-03 | 43,430 | 1.37 | 59,499 |
| KERX | Keryx Biopharmaceuticals Inc | 2018-06-11 | 17,333 | 3.36 | 58,239 |
| SCYX | SCYNEXIS Inc | 2020-12-21 | 4,000 | 1.63 | 6,520 |
| CFRXQ | ContraFect Corp | 2017-07-25 | 26 | 0.00 | 0 |
Holding Weightings of Steven C Gilman
Steven C Gilman Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven C Gilman has made a total of 5 transactions in Vericel Corp (VCEL) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Vericel Corp is the sale of 5,000 shares on September 4, 2024, which brought Steven C Gilman around $242,900.
According to the SEC Form 4 filings, Steven C Gilman has made a total of 3 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Momenta Pharmaceuticals Inc is the sale of 13,000 shares on August 5, 2020, which brought Steven C Gilman around $425,750.
According to the SEC Form 4 filings, Steven C Gilman has made a total of 4 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 4,567 shares on June 3, 2022, which brought Steven C Gilman around $1,644.
More details on Steven C Gilman's insider transactions can be found in the Insider Trading History of Steven C Gilman table.Insider Trading History of Steven C Gilman
- 1
Steven C Gilman Trading Performance
GuruFocus tracks the stock performance after each of Steven C Gilman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven C Gilman is 54.51%. GuruFocus also compares Steven C Gilman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven C Gilman within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven C Gilman's insider trading performs compared to the benchmark.
Performance of Steven C Gilman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.22 | | | | | |
| Relative Return to S&P 500(%) | 21.56 | | | | | |
Steven C Gilman Ownership Network
Steven C Gilman Owned Company Details
What does Momenta Pharmaceuticals Inc do?
Who are the key executives at Momenta Pharmaceuticals Inc?
Steven C Gilman is the director of Momenta Pharmaceuticals Inc. Other key executives at Momenta Pharmaceuticals Inc include Chief Legal Officer Alejandra Carvajal , Chief Scientific Officer Anthony M. Manning , and SVP & Chief Medical Officer Santiago Arroyo .
Momenta Pharmaceuticals Inc (MNTA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc (MNTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc (MNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Momenta Pharmaceuticals Inc (MNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Momenta Pharmaceuticals Inc Insider Transactions
Steven C Gilman Mailing Address
Above is the net worth, insider trading, and ownership report for Steven C Gilman. You might contact Steven C Gilman via mailing address: 110 Hartwell Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
